Latest news with #CLEAR®Verified
Yahoo
08-04-2025
- Business
- Yahoo
Enphase Energy Announces Conference Call to Review First Quarter 2025 Financial Results
Tuesday, April 22, 2025 at 4:30 p.m. Eastern Time FREMONT, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, April 22, 2025 at 4:30 p.m. Eastern Time to discuss its first quarter 2025 financial results for the period ended March 31, 2025. The live webcast can be accessed on the Enphase Energy Investor Relations website at and a recorded version of the call will also be available there approximately one hour after the call. What: Enphase Energy's First Quarter 2025 Financial Results Earnings Conference Call and Webcast Date: Tuesday, April 22, 2025 Time: 4:30 p.m. Eastern Time Live Call: 833.634.5018 International: +1.412.902.4214 Replay: United States: 877.344.7529International: +1.412.317.0088Canada: 855.669.9658Replay access code: 9557806 About Enphase Energy, Inc. Enphase Energy, a global energy technology company based in Fremont, CA, is the world's leading supplier of microinverter-based solar and battery systems that enable people to harness the sun to make, use, save, and sell their own power — and control it all with a smart mobile app. The company revolutionized the solar industry with its microinverter-based technology and builds all-in-one solar, battery, and software solutions. Enphase has shipped approximately 80.0 million microinverters, and approximately 4.7 million Enphase-based systems have been deployed in more than 160 countries. For more information, visit ©2025 Enphase Energy, Inc. All rights reserved. Enphase Energy, Enphase, the 'e' logo, IQ, and certain other marks listed at are trademarks or service marks of Enphase Energy, Inc. in the U.S. and other countries. Other names are for informational purposes and may be trademarks of their respective owners. Contact: Zach FreedmanEnphase Energy, Relationsir@ This press release was published by a CLEAR® Verified in to access your portfolio
Yahoo
03-03-2025
- Business
- Yahoo
Altimmune to Participate in the Leerink Global Healthcare Conference
GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company's management team will participate in a fireside chat at the Leerink Global Healthcare Conference. Details are as follows: Conference: Leerink Global Healthcare Conference Date/Time: Monday, March 10, 2025, at 3:40 p.m. EST The session will be webcast and can be accessed by visiting the Events section of the Altimmune website. About Altimmune Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter Company Contact:Greg WeaverChief Financial OfficerPhone: 240-654-1450ir@ Investor Contact:Lee RothBurns McClellanPhone: 646-382-3403lroth@ Media Contact:Danielle CanteyInizio Evoke, BiotechPhone: This press release was published by a CLEAR® Verified in to access your portfolio
